Anavex Reports Fiscal Third Quarter 2017 Financial Results

Anavex Reports Fiscal Third Quarter 2017 Financial Results

NEW YORK – August 7, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...
Anavex Reports Fiscal Second Quarter 2017 Financial Results

Anavex Reports Fiscal Second Quarter 2017 Financial Results

NEW YORK – May 10, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...